ACADIAN ASSET MANAGEMENT LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 56 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q4 2022$74
-99.9%
129,212
+212.9%
0.00%
-100.0%
Q2 2021$144,000
+65.5%
41,300
+158.8%
0.00%
Q3 2019$87,000
-70.9%
15,956
-36.5%
0.00%
-100.0%
Q2 2019$299,000
+464.2%
25,143
+148.4%
0.00%
Q1 2019$53,000
-81.9%
10,122
-80.0%
0.00%
-100.0%
Q1 2018$293,00050,6030.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders